3 hours Annovis Bio (NYSE:ANVS) Rating Reiterated by HC WainwrightMarketBeat
HC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Annovis Bio in a report on Wednesday.
XHC Wainwright restated a “buy” rating and issued a $30.00 price objective on shares of Annovis Bio in a report on Wednesday.
X